WNK1 and pseudohypoaldosteronism type 2: Pseudohypoaldosteronism type II (PHAII), characterized by hypertension, hyperkalemia, and metabolic acidosis (Hadchouel et al., 2016), results from mutations in WNK kinase family members WNK1 and WNK4 (Wilson et al., 2001).